中国实用外科杂志

• 普通外科进展 • 上一篇    下一篇

结直肠癌同时性肝转移的手术时机与术式选择

陈进宏王祥宇   

  1. 复旦大学附属华山医院普通外科 复旦大学肿瘤转移研究所,上海200040
  • 出版日期:2018-02-01 发布日期:2018-02-24

  • Online:2018-02-01 Published:2018-02-24

摘要:

临床上有15%~25%的结直肠癌病人在原发肿瘤确诊时或确诊前就伴有肝转移,即同时性肝转移(sCRLM)。随着治疗理念的进步以及外科技术的提高,sCRLM的临床治疗已发生了革命性的变化,也出现了一些困惑与争议。新辅助化疗对于特定病人,尤其是存在高危复发因素的病人具有潜在应用价值。原发灶与肝转移灶同期切除术的安全性和有效性已得到验证,“肝转移灶优先切除”的理念也得以实施。以腹腔镜及机器人手术为代表的微创技术下的sCRLM同期切除较传统开放手术显示出一定的优势。然而,循证医学证据缺乏是目前sCRLM临床治疗面临的最大困难,新辅助治疗的地位、分期切除顺序的选择、同期切除病人的甄别以及微创技术的应用仍有待进一步探索和研究。

关键词: 结直肠癌肝转移, 同时性肝转移, 新辅助治疗疗, 同期切除, 分期切除, 腹腔镜

Abstract:

Choice of timing and approach for surgical treatment of synchronous colorectal liver metastases        CHEN Jin-hong,WANG Xiang-yu. Department of General Surgery,Huashan Hospital,Fudan University, Cancer Metastasis Institute,Fudan University,Shanghai 200040,China
Corresponding author: CHEN Jin-hong, E-mail: jinhongch@
hotmail.com
Abstract    Approximately 15% to 25% of colorectal cancer patients may present with synchronous liver metastasis (sCRLM) at or before diagnosis of the primary tumor. In recent years, the development of treatment concept and surgical techniques has lead to revolutionary changes in clinical management of sCRLM, which also brings some confusion and debates. Compared to direct operation, the addition of neoadjuvant chemotherapy may have potential clinical efficacy in specific sCRLM patients, especially in those who harbor high-risk recurrence factors. Combined resection of the primary tumor and liver metastases arises in recent years, and its safety and effectiveness have been validated. Meanwhile, “liver first approach” for staged resection has also been proposed and implemented in some centers. Lastly, minimally invasive (laparoscopic and robot-assisted) surgery could further improve the clinical efficacy of combined resection of sCRLM than traditional open approach. However, The lack of validated evidence is the biggest difficulty in clinical treatment of sCRLM. The status of neoadjuvant therapy, sequence choice of staged resection, patients screening of combined resection and the application of minimally invasive technology need further exploration and research.

Key words: colorectal liver metastasis, synchronous liver metastasis, neoadjuvant therapy, combined resection, staged resection, laparoscope